A study to determine the frequency of lower limb oedema occuring in a patient diagnosed with penile cancer.
Not Applicable
- Conditions
- Health Condition 1: C609- Malignant neoplasm of penis, unspecified
- Registration Number
- CTRI/2022/12/048335
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients diagnosed with penile cancers and posted for treatment (Surgery including ILND
with /without Radiation Therapy) with curative intent at TMH Mumbai, ACTREC kharghar and
HBCH Varanasi.
2.Age > 18.
3.Patients planned for Surgery and or Radiation therapy and or Chemotherapy including Neo
adjuvant chemotherapy (NACT)
4.Willing to comply with the Surveillance program.
5.Can read or comprehend either English, Hindi or Marathi.
Exclusion Criteria
1.Patients with unresectable recurrent groin node disease.
2.Patients with swelling/ lymphedema in lower limb at the time of diagnosis of penile
cancer.
3.Locally advanced penile cancer patients scheduled for NACT
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the incidence of lower limb lymphedema in patients treated for penile cancer <br/ ><br>with ILND with / without radiation therapy using prospective surveillance program.Timepoint: until 1 year from enrollment
- Secondary Outcome Measures
Name Time Method 1. To identify early stage ( 5% 10% volume difference) lower limbs lymphedema in Indian <br/ ><br>patients treated for penile cancers with IILND with / without radiation therapy using prospective <br/ ><br>surveillance program.Timepoint: at week 2 and week 6 from the day of surgery